Restatement of Previously Issued Financial Statements (Tables)

12 Months Ended

Dec. 31, 2020

Accounting Changes And Error Corrections [Abstract]

Summary of Effect of the Restatement on Financial Statement Line Items

The following table summarizes the effect of the restatement on each financial statement line items as of December 31, 2020, or for the year ended December 31, 2020, as indicated:

	December 31, 2020
	As Previously Reported			Adjustments			As Restated
Balance Sheet:
Derivative liabilities	$	—		$	59,536,667		$	59,536,667
Total current liabilities		533,908			59,536,667			60,070,575
Total liabilities		16,283,908			59,536,667			75,820,575
Redeemable Equity		429,534,010			20,471,927			450,005,937
Class A ordinary shares		205			(205	)		—
Additional paid-in capital		5,644,534			(5,644,534	)		—
Accumulated deficit		(645,860	)		(74,363,855	)		(75,009,715	)
Total shareholders' (deficit) equity		5,000,004			(80,008,594	)		(75,008,590	)
	For the Year Ended December 31, 2020
	As Previously Reported			Adjustments			As Restated
Statement of Operations:
Professional fees, offering costs and other expenses	$	643,303		$	752,751		$	1,396,054
Change in fair value of derivatives		—			31,926,667			31,926,667
Loss from operations		(643,303	)		(32,679,418	)		(33,322,721	)
Net loss attributable to ordinary shares		(637,366	)		(32,679,418	)		(33,316,784	)
Basic and diluted net loss per Class A ordinary share		—			(2.58	)		(2.58	)
Basic and diluted net loss per Class F ordinary share		—			(0.37	)		(0.37	)
Statement of Cash Flows:
Net loss attributable to ordinary shares	$	(637,366	)	$	(32,679,418	)	$	(33,316,784	)
Change in accrued professional fees and other expenses		440,322			752,751			1,193,073
Change in fair value of derivatives		—			31,926,667			31,926,667